Long-Term Results of Percutaneous Transluminal Angioplasty in Renovascular Hypertension

Knorring, Johan von; Edgren, J; Lepäntalo, Mauri

doi:10.1177/02841851960371p107

Cited by 37 publications

(16 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There have been few studies making a direct comparison of surgical revascularisation with PTRA. One such study clearly demonstrated benefit of the former over the latter 107. No direct comparison between surgical revascularisation and PTRA plus stenting has been undertaken.…”

Section: Treatmentmentioning

confidence: 99%

Atherosclerotic renal artery stenosis: from diagnosis to treatment

Carmichael

1999

Postgraduate Medical Journal

View full text Add to dashboard Cite

show abstract

Section: Treatmentmentioning

confidence: 99%

Atherosclerotic renal artery stenosis: from diagnosis to treatment

Carmichael

1999

Postgraduate Medical Journal

View full text Add to dashboard Cite

show abstract

“…The introduction of percutaneous transluminal renal angioplasty (PTRA) for the management of patients with RVH was expected to improve BP control and reduce the need for multiple antihypertensive drugs [50][51][52][53]. Surgery and PTRA are similarly effective but PTRA is associated with significantly lower risk of complications [54].…”

Section: Managementmentioning

confidence: 99%

Atherosclerotic Renal Artery Stenosis: An Update on Diagnosis and Management

Stavrinou

Koumaras²,

Gossios³

et al. 2011

CVP

View full text Add to dashboard Cite

Atherosclerotic renal artery stenosis (ARAS) is a progressive disease and it is usually associated with hypertension as well as with chronic kidney and cardiovascular disease. Although the anatomical lesions are relatively easy to depict, there is need to identify diagnostic methods to establish the functional significance of the stenosis and predict the response to revascularization. Over the last years, renal revascularization appears to be increasingly performed in patients with ARAS. However, controversy abounds as so far prospective, randomised trials did not document any benefit of revascularization with or without stenting plus optimal medical treatment over optimal medical treatment alone. In this review, we discuss the current data in the field of diagnosis and management of patients with ARAS.

show abstract

“…Satisfying acute and long-term results after angioplasty of nonostial stenoses caused by FMD and atherosclerosis were realized with procedural success rates of 82% to 100% and restenosis rates of approximately 10%, respectively [43][44][45][46]. However, long-term success rates of treated ostial atherosclerotic lesions are limited to 50% to 62% due to acute technical problems such as dissection, elastic recoiling, and rigidity of the lesion.…”

Section: Treatmentmentioning

confidence: 99%

Renal artery stenosis

Zeller

2007

Curr Treat Options Cardio Med

View full text Add to dashboard Cite

Fibromuscular dysplasia (FMD) and aortoarteritis are the most frequent causes of secondary hypertension induced by renal artery stenosis (RAS). Revascularization of this disease entity usually cures arterial hypertension. Demographic evolution leads to an increasing incidence of atherosclerotic RAS, one of the major causes of end-stage renal failure. Furthermore, atherosclerotic RAS leads to deterioration of primary hypertension, progression of atherosclerosis manifestation such as occlusive and aneurysmatic peripheral artery disease, and chronic or acute organ damage such as left ventricular hypertrophy and recurrent flash pulmonary edema. Despite the lack of sufficiently powered randomized controlled trials, each hemodynamically relevant RAS (eg, > or = 70%) should be considered for stent angioplasty in patients without end-stage ischemic nephropathy or limited life expectancy due to concomitant disease (eg, cancer). Drug-eluting stents will probably reduce the overall low in-stent restenosis rate of 10% to 20%. Interventions in patients with dialysis-dependent end-stage nephropathy are left to appropriate clinical study protocols.

show abstract

Long-Term Results of Percutaneous Transluminal Angioplasty in Renovascular Hypertension

Abstract: The result suggest that PTRA is effective in long-term management of renovascular hypertension, not only in patients with fibromuscular stenosis, but also in patients with atherosclerotic disease, even when ostial lesions are present.

Cited by 37 publications

References 16 publications

Atherosclerotic renal artery stenosis: from diagnosis to treatment

Atherosclerotic renal artery stenosis: from diagnosis to treatment

Atherosclerotic Renal Artery Stenosis: An Update on Diagnosis and Management

Renal artery stenosis

Contact Info

Product

Resources

About